Khandakar, G.I.; Satoh, R.; Takasaki, T.; Fujitani, K.; Tanabe, G.; Sakai, K.; Nishio, K.; Sugiura, R.
ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells. Cells 2022, 11, 702.
https://doi.org/10.3390/cells11040702
AMA Style
Khandakar GI, Satoh R, Takasaki T, Fujitani K, Tanabe G, Sakai K, Nishio K, Sugiura R.
ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells. Cells. 2022; 11(4):702.
https://doi.org/10.3390/cells11040702
Chicago/Turabian Style
Khandakar, Golam Iftakhar, Ryosuke Satoh, Teruaki Takasaki, Kana Fujitani, Genzoh Tanabe, Kazuko Sakai, Kazuto Nishio, and Reiko Sugiura.
2022. "ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells" Cells 11, no. 4: 702.
https://doi.org/10.3390/cells11040702
APA Style
Khandakar, G. I., Satoh, R., Takasaki, T., Fujitani, K., Tanabe, G., Sakai, K., Nishio, K., & Sugiura, R.
(2022). ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells. Cells, 11(4), 702.
https://doi.org/10.3390/cells11040702